LITTLE FLY

Owners

Goods & Services

Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit vector-borne diseases; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of vector-borne pathogen genes; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit mosquito populations; Research and development of genetically engineered organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of vector-borne pathogen genes; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit mosquito populations; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce interfering molecules that alter mosquito behavior; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce interfering molecules that alter mosquito behavior, namely, the inhibition of a mosquito's appetite and inhibition of a mosquito's olfactory perception; Research and development of new biological products for therapeutic use to prevent or treat vector-borne diseases